Angus reports on the basic research, clinical science, and drug development that may transform survival and quality of life for patients, as well as developments affecting the cancer community. You ...

A bone marrow transplant, or stem cell transplant, places blood stem cells back into the body. The transplant replaces cells that cancer or treatments have destroyed. People may have a bone marrow ...

Stem cell transplants remain essential for blood cancers, with expanded donor options including half-matched family members and umbilical cord blood. Cyclophosphamide has improved graft-versus-host ...

A phase IIA clinical trial to evaluate a reversible Bruton’s tyrosine kinase inhibitor (BTKi) HBW-3220 capsules in patients with relapsed/refractory (R/R) B-cell non-Hodgkin lymphoma (B-NHL).

In-hospital outcome of patients hospitalized for leukemia with comorbid acute decompensated heart failure: An analysis of National Inpatient Sample (NIS). Effect of iPSC-derived NK cells with ...

The study found no significant OS or PFS improvement with auto-HCT plus Rituxan versus Rituxan alone in MCL patients in first complete remission with undetectable MRD. Three-year OS rates were 82.1% ...

Please provide your email address to receive an email when new articles are posted on . Auto-HCT linked to improved PFS and reduced relapse rate for patients achieving a complete remission.

For people living with multiple sclerosis (MS), the search for effective treatment options can feel like a never-ending journey. While disease-modifying therapies (DMTs) have improved outcomes for ...

Dr. Soliman Fakeeh Hospital in Jeddah has achieved a new medical milestone by successfully performing the first autologous stem cell transplant in Saudi Arabia’s private healthcare sector for a ...

New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, shows that patients with refractory juvenile systemic sclerosis improved significantly on nearly all ...